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ABStrAct                        The aim of the present study was to investigate the antifungal effect of Bacillus 
mojavensis SZMC 22228 against different dermatophytes and to isolate the antidermatophytic 
compound from the bacterial ferment broth. B. mojavensis SZMC 22228 and its cell-free fer-
ment broth effectively inhibited the growth of clinical reference strain of Microsporum canis, 
Microsporum gypseum, Trichophyton mentagrophytes, Trichophyton rubrum and Trichophyton 
tonsurans in agar diffusion test in vitro. An antidermatophytic, ~25 kDa protein (B. mojaven-
sis SZMC 22228 antidermatophyitc protein, BMAP) was purified from the antifungally active, 
cell-free ferment broth using size exclusion and ion-exchange chromatography. BMAP showed 
antifungal effect against all of the investigated dermatophytes both in agar diffusion and broth 
microdilution susceptibility tests. M. gypseum proved to be the most susceptible dermatophyte 
to BMAP (MIC=40 µg/ml), all the other investigated fungi were less susceptible (MIC=80 µg/ml). 
The enzymatic activity of this protein was investigated in microtiter plate assay using hydrolase 
specific chromogenic substrates. BMAP showed high proteolytic activity towards N-Succ-Ala-
Ala-Pro-Phe-pNA, and proved to be a chymotrypsin-like protease. These results suggest that 
the antidermatohytic activity of B. mojavensis SZMC 22228 correlates with its chymotrypsin-like 
protease production. After further investigations, the purified BMAP could be a promising base 
of a novel antidermatophytic strategy. Acta Biol Szeged 58(2):157-162 (2014)
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The worldwide distributed dermatophytes are a group of 
keratinophilic fungi. They are highly adapted to digest 
keratinous debris thus these fungi are capable of invading 
the superficial layer of the skin, hair, and nails of humans 
and other vertebrates (Bond 2010; Leite Jr et al. 2014). 
Approximately 40% of the human population is affected in 
worldwide (Leite Jr et al. 2014), but the spectrum of isolated 
dermatophytes is diverse in time and geography (Havlickova 
et al. 2008; Seebacher et al. 2008). They rarely cause life-
threatening infection in healthy individuals, but they may have 
a debilitating effect on the patients and affect their quality of 
life (Rotta et al. 2012). However, it is a well-known fact that 
the incidence of superficial and fatal systemic dermatophyte 
infections has been increasing continuously during recent 
years as a consequence of the rise in the number of immu-
nocompromised patients (Rotta et al. 2012). The choice of 
the appropriate therapy in the cases of these patients is not 
simple because of the possible drug interactions and severe 
side effects (Dias et al. 2103). The more frequent occurrence 
of antimycotic resistant dermatophyte strains further sharpens 
this problem (Jones 1990; Mukherjee et al. 2003; Martinez-
Rossi et al. 2008). Therefore, there is a substantial demand 
for new safely applicable antidermatophytic compounds 
without side effects.
Biologically active substances secreted by the members 
of Bacillus genus are promising compounds of drug industry 
for development of novel antifungal agents (Tserkovniak et al. 
2009). The plant endophyte Bacillus mojavensis is a relatively 
new member of the Bacillus genus (Nair et al. 2002; Bacon 
and Hinton 2011). This species is closely related to Bacillus 
subtilis complex, but it can be distinguishable based on the 
fatty acid composition, DNA sequence, and the resistance 
to genetic transformation (Bacon and Hinton 2011). Several 
studies reported that B. mojavensis actively secretes different 
compounds with remarkable or potential antifungal activity, 
e.g. lipopeptides such as surfactin, iturin, fengycin; proteases, 
cellulases (Youcef-Ali et al. 2014). Due to this feature B. 
mojavensis is also known as an effective biocontrol agent 
against plant and post-harvest pathogenic filamentous fungi 
(Bacon and Hinton 2011).
This paper describes the antidermatophytic activity of 
a B. mojavensis strain isolated from mumijo, a traditional 
Mongolian medicine (Galgóczy et al. 2011); furthermore, the 
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isolation and identification of an extracellular chymotrypsin-
like protease (B. mojavensis SZMC 22228 antidermatophyitc 
protein, BMAP) which plays a role in it.
Materials and Methods
Strains and media
The following clinical reference dermatophyte strains were 
used in the present study: Microsporum canis (American Type 
Culture Collection, USA; ATCC 36299), Microsporum gyp-
seum (ATCC 24102), Trichophyton mentagrophytes (ATCC 
9533), Trichophyton rubrum (ATCC 28188) and Trichophyton 
tonsurans (ATCC 28942). All these isolates were maintained 
on potato dextrose agar (PDA, Sigma-Aldrich, St Louis, 
MO, USA) slants at 4 °C. For inoculum preparation they 
were subcultured onto oatmeal agar (10 g/l oatmeal, 1.5 g/l 
KH
2
PO
4
, 1 g/l NaNO
3
, 1 g/l MgSO
4
, 20 g/l agar) to induce 
conidium production (Jessup et al. 2000; Ghannoum et al. 
2006). Antifungal activity tests were performed in PDA 
plates. B. mojavensis SZMC 22228 was maintained on LB 
(10 g/l tryptone, 2 g/l yeast extract, 10 g/l NaCl, 20 g/l agar, 
pH 7.0) slant and was grown in low salt LB broth (LSLB: 
10 g/l tryptone, 5 g/l yeast extract, 5 g/l NaCl, pH 7.0) for 
investigation of antifungal activity of the cell-free ferment 
broth and for purification of the BMAP.
Isolation and molecular identification of B. 
mojavensis SZMc 22228
B. mojavensis was isolated from a Mongolian mumijo prepa-
ration (Galgóczy et al. 2011) and indentified for partial se-
quencing of the gyrA gene according to Reva et al. (2004). 
After sequencing (performed at LGC Genomics GmbH, 
Berlin, Germany) of the amplified partial gyrA gene, the 
result was compared with similar sequences available in 
the National Center for Biotechnology Information (NCBI) 
database using Basic Local Alignment Search Tool (BLAST) 
(Altschul et al. 1990).
Purification of B. mojavensis SZMc 22228 
antidermatophytic protein (BMAP)
BMAP was isolated from the ferment broth of B. mojavensis 
SZMC 22228, which was cultivated in 250-ml Erlenmeyer 
flask containing 100 ml LSLB inoculated with 105 bacteria, 
and incubated at 30 °C for 48 h under continuous shaking 
(160 rpm). After bacterial cell harvest (30 min, 10.000×g, 
4 °C), the supernatant was filtered (MILLEX-HP, pore size: 
0.45 µm, Millipore, Billerica, MA, USA) then the extracel-
lular protein fraction was precipitated with 80% of am-
monium sulfate at 4 °C for 24 h. Precipitated proteins were 
collected by centrifugation (30 min, 10.000×g, 4 °C) and 
resuspended in 10 ml of 20 mM Tris buffer (pH 7.2). This 
protein solution was dialyzed (Snake Skin dialysis tubing, 
3.5K MWCO, Thermo Scientific, Logan, UT, USA) against 
20 mM Tris buffer (pH 7.2) in 1:100 volume ratio based on 
the instruction of manufacturer at 4 °C for 48 h with buffer 
changing after 24 h.
The different molecular weight protein fractions of the 
ten-fold concentrated sample were separated with size exclu-
sion chromatography. The column (20×250 mm, Sephadex 
G-50, GE Healthcare, Uppsala, Sweden) was equilibrated 
with 20 mM Tris buffer (pH 7.2). Protein fractions were 
eluted (flow rate: 2 ml/min) with the above mentioned buf-
fer. Protein fractions which showed high antidermatophytic 
activity in agar diffusion test (data not shown) were pooled, 
concentrated to six-fold, and then this solution was separated 
with centrifugal ultrafiltration (Corning® Spin-X® UF 20 ml 
Centrifugal Concentrator, 30,000 MWCO Membrane, Corn-
ing, Tewksbury, MA, USA). The <30 kDa fraction (showed 
antidermatophytic effect in agar diffusion test, data not 
shown) was dialyzed against 20 mM Tris buffer (pH 7.2), 
then purified with ion-exchange chromatography on a CM 
Sepharose Fast Flow (Sigma-Aldrich, St Louis, MO, USA) 
column (13×60 mm, equilibrated with 20 mM Tris buffer (pH 
7.2) at a flow rate of 1 ml/min. The proteins were eluted with 
a NaCl gradient (0.1-1.0 M) prepared in the equilibrating 
buffer. The protein fractions were dialyzed against 20 mM 
Tris buffer (pH 7.2); finally, they were sterilized by filtration 
(MILLEX-HP, pore size: 0.45 µm, Millipore, Billerica, MA, 
USA) and their antidermatophytic activity was investigated 
in agar diffusion test. Protein content of the different fractions 
was checked in SDS-PAGE (NuPAGE Novex 4-12% Bis-Tris 
Gel, 1.0 mm, 10 well, Invitrogen-Life Technologies, Eugene, 
OR, USA) visualized with Coomassie Brilliant Blue R-250 
and silver staining. Purification experiments were repeated 
three times.
Antidermatophytic activity assays
Fungal inocula were prepared as described previously (Gal-
góczy et al. 2008). An agar diffusion technique was used 
to estimate the antagonism ability of B. mojavensis SZMC 
22228 and the size of growth inhibition caused by the cell-
free bacterial ferment broth (filtered through MILLEX-HP, 
pore size: 0.45 µm) and the purified BMAP. Solid culture 
medium (PDA) was overlaid with 1 ml of potato dextrose 
broth (PDB, Sigma-Aldrich, St Louis, MO, USA; pH 7.0) that 
were inoculated with 106 microconidia/ml and was dried. For 
the investigation of antagonism ability, 10 µl 104 bacteria/ml 
suspended in LB was dropped on the surface of this plate and 
was dried. For investigation of the antifungal activity of B. 
mojavensis SZMC 22228 cell-free ferment broth and purified 
BMAP, an agar diffusion technique was used: 100 µl of sterile 
bacterial ferment broth or BMAP (160 µg/ml) diluted in 20 
mM Tris buffer (pH 7.2) were filled into the wells of inocu-
lated PDA plates. Sterile LSLB or Tris buffer (pH 7.2) was 
used as negative control. Diameters of the inhibition zones 
were measured after incubation at 30 °C for 72 h.
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Minimal inhibitory concentrations (MIC) of BMAP 
against the investigated dermatophytes were determined 
in broth microdilution susceptibility test using flat-bottom 
96-well microtiter plate. One hundred microliter of BMAP 
diluted in PDB was mixed with 100 µl of microconidial sus-
pension (105 microconidia/ml) prepared also in PDB. The 
final concentrations of BMAP were 160, 80, 40, 20, 10, 5, 
2.5 and 1.25 µg/ml. The plates were incubated at 30 °C for 
72 h, and the optical densities were then measured at 620 nm 
with microtiter plate reader (ASYS Jupiter HD-ASYS Hitech, 
Salzburg, Austria). Two hundred microliter fresh PDB was 
used as background for the spectrophotometric calibration. 
To determine MICs, optical densities of the untreated control 
cultures (100 µl of microconidial suspension mixed with 100 
µl PDB) were referred to 100% of growth, in each case. MIC 
was defined as the lowest BMAP concentration at which 
growth was not detected on the basis of the OD
620
 values 
as compared with the untreated control. Antifungal activity 
experiments were repeated three times.
enzymatic activity assays
The enzymatic activity of BMAP was determined in 96-
well microtiter plate by the use of N-bz-Phe-Val-Arg-pNA, 
N-α-bz-L-Arg-pNA, N-acetyl-L-Leu-pNA, N-Succ-Ala-Ala-
Pro-Phe-pNA, p-nitrophenyl-N-acetyl-β-D-glucosaminide, 
p-nitrophenyl-N,N’-diacetyl-β-D-chitobioside, p-nitrophenyl-
β-D-N,N′,N′′-triacetylchitotriose, p-nitrophenyl-β-D-
cellobioside, and p-nitrophenyl-β-glucopyranoside. All 
substrates were purchased from Sigma-Aldrich (St Louis, 
MO, USA). Twenty microliter of 1 mg/ml substrate was 
given to 80 µl of 40 µg/ml BMAP (diluted in 20 mM Tris 
buffer; pH 7.2) and incubated for 3 h at 30 °C. The reaction 
was stopped by addition of 25 µl 10% (w/v) sodium car-
bonate and the p-nitrophenol or p-nitroaniline release was 
measured at 405 nm using an ASYS Jupiter HD microplate 
reader. Twenty microliter of 1 mg/ml substrate mixed with 
20 mM Tris buffer (pH 7.2) was used as background for the 
spectrophotometric calibration. Enzymatic activity assays 
were repeated three times.
results
Isolation and identification of B. mojavensis 
SZMc 22228
The BLAST analysis of the amplified partial gyrA sequence 
revealed 99% similarity to the partial gyrA sequence of 
B. mojavensis NRRL BD-600 strain (accession number: 
EU138644). Based on this result, the Bacillus strain isolated 
from Mongolian mumijo preparation was identified as B. 
mojavensis. This B. mojavensis strain was deposited in the 
Szeged Microbiological Collection (SZMC, http://www2.
sci.u-szeged.hu/microbiology/collection.htm) under the 
SZMC 22228 number, and the partial gyrA gene sequence 
in the European Nucleotide Archive under the HG964636 
identifier.
Antifungal activity of B. mojavensis SZMc 22228 
and its ferment broth
The isolated B. mojavensis SZMC 22228 effectively inhibited 
the growth of M. canis, M. gypseum, T. mentagrophytes, T. 
rubrum and T. tonsurans in different rates (Table 1). The cell-
free ferment broth of B. mojavensis SZMC 22228 also showed 
antidermatophytic activity on these isolates in the applied agar 
diffusion test (Table 1). In these tests M. canis (58.0±10.5 
mm inhibition zone caused by B. mojavensis SZMC 22228) 
and M. gypseum (18.3±2.1 mm inhibition zone caused by the 
cell-free ferment broth of B. mojavensis SZMC 22228) were 
the most susceptible dermatophytes (Table 1).
Purification of B. mojavensis SZMc 22228 
antidermatophytic protein (BMAP) and its 
antifungal activity
Gel electrophoresis revealed the presence of a protein with 
a molecular mass of approx. 25 kDa in the purified fraction 
of the ferment broth which had antidermatophytic activity 
(BMAP, Figure 1). After purification the final yield of BMAP 
from three independent productions was 3.64±0.53 mg. One 
hundred sixty microgram per milliliter BMAP was able to in-
hibit the growth of M. canis, M. gypseum, T. mentagrophytes, 
T. rubrum and T. tonsurans causing inhibition halos with dif-
ferent diameters in agar diffusion tests (Table 1). M. gypseum 
(inhibition zone: 23.7±3.1 mm) was the most susceptible 
isolate (Table 1). Based on these results we suppose that the 
isolated ~25 kDa molecular weight BMAP plays a role in 
the antidermatophytic effect. The purified BMAP maintained 
Table 1. Antidermatophytic activity of the Bacillus mojavensis 
SZMC 22228, its cell-free ferment broth and the 160 µg/ml puri-
fied ~25 kDa antidermatophytic protein (BMAP) in agar diffu-
sion test on PDA after incubation at 30 °C for 72 h.
Species
Diameter of inhibition zone (mm)
B. mojav-
ensis
SZMC 
22228
Cell-free 
ferment 
broth
160 µg/ml 
BMAP
Microsporum canis
ATCC 36299
58.0±10.5 14.3±2.1 15.3±2.9
Microsporum gypseum
ATCC 24102
48.0±2.9 18.3±2.1 23.7±3.1
Trichophyton mentagro-
phytes
ATCC 9533
53.3±14.5 12.0±3.0 14.7±1.5
Trichophyton rubrum
ATCC 28188
32.7±11.6 15.0±2.6 17.30±0.6
Trichophyton tonsurans
ATCC 28942
56.7±12.6 16.3±2.1 18.3±2.3
Standard deviations (±SD) derived from three replicates (N=3).
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its antifungal activity against all investigated dermatophytes 
in broth microdilution susceptibility test, and also the M. 
gypseum proved to be the most susceptible fungus (MIC = 
40 µg/ml). All the other dermatophytes were less susceptible 
(MIC = 80 µg/ml).
enzymatic activity assays
BMAP did not show enzymatic activity towards N-acetyl-
L-Leu-pNA, p-nitrophenyl-N-acetyl-β-D-glucosaminide, 
p-nitrophenyl-N,N’-diacetyl-β-D-chitobioside, p-nitro-
phenyl β-D-N,N′,N′′-triacetylchitotriose, p-nitrophenyl-
β-D-cellobioside, p-nitrophenyl-β-glucopyranoside, 
p-nitrophenyl-N-acetyl-β-D-glucosaminide; but hydrolysed 
the N-α-bz-L-Arg-pNA, N-bz-Phe-Val-Arg-pNA, N-Succ-
Ala-Ala-Pro-Phe-pNA proteolytic substrates. The most 
effective proteolytic activity was exerted on N-Succ-Ala-
Ala-Pro-Phe-pNA (Figure 2). Based on these results and 
the amount of the released p-nitroaniline from digested 
proteolytic substrates (Figure 2), BMAP is considered as a 
chymotrypsin-like protease.
discussion
Several B. mojavensis strains are considered as biocontrol 
agents because they can enhance plant growth and protect 
the plant against its fungal pathogens due to the produced 
surfactin, iturin, fengycin and various enzymes. Although, 
the factors which are responsible for growth enhancement 
are unknown but the antifungal mechanism of the biocontrol 
strains is well-characterized especially on Fusarium verticil-
lioides (Bacon and Hinton 2011). Growth inhibition ability 
of B. mojavensis on other plant pathogenic (e.g. Ambrosiella 
macrospora, Botrytis cinerea, Fusarium oxysporum, Fusar-
ium moniliforme, Macrophomina phaseolina, Mucor ram-
manianus, Alternaria solani, Phytophthora meadii, Pythium 
aphanidermatum and Rhizoctonia solani), and (opportunistic) 
human pathogenic (such as Aspergillus flavus, Aspergillus 
niger, Candida utilis, Candida albicans and Rhizopus spp.) 
fungi was demonstrated by previous studies (Nair et al. 2002; 
Maachiaet al. 2011; Youcef-Ali et al. 2014). In our work 
we observed that B. mojavenis SZMC 22228 can inhibit ef-
fectively the growth of different dermatophytes. Such kind 
antifungal activity of B. mojavenis has not been reported in 
the literature yet; however, data are available about the an-
tidermatophytic effect of other Bacillus species. Previously, 
it was proven that Bacillus amyloliquefaciens HNA3 exerts 
growth inhibition effect on T. mentagrophytes (Nastro et al. 
2011) and different B. subtilis isolates on Trichophyton and 
Microsporum spp. (Kumar et al. 2005, 2009; Lukmanova 
et al. 2008). Kumar et al. (2009) observed that a peptide 
belonging to the group of antifungal antibiotic peptides is 
responsible for this effect. Compared to this finding, a ~25 
kDa extracellular chymotrypsin-like protease (BMAP) plays 
a role in the antidermatophyotic activity of B. mojavensis 
SZMC 22228.
Numerous species of Bacillus have been involved in 
industrial protease production and B. mojavensis is also 
considered as a great source of different (alkaline) proteases 
(Schallmey et al. 2004). Three different alkaline proteases 
from B. mojavensis A21 strain have been isolated, which 
show differences in their molecular weight (15-29 kDa) and 
enzymatic features, such as specific activity, pH and thermal 
optimum/stability, and calcium-dependence (Haddar et al. 
2009a, 2009b). Proteases showing same substrate specific-
ity as BMAP were isolated from the ferment broth of B. 
mojavensis-related B. subtilis strains. A 30 and 43-46 kDa 
molecular weight fibrinolytic enzymes with high activity to 
N-Succ-Ala-Ala-Pro-Phe-pNA chromogenic substrate were 
purified from the ferment broth of B. subtilis DC33 and Bacil-
lus sp. nov. SK006 (Wang et al. 2006; Hua et al. 2008). The 
antifungal activity of these proteases has not been investigated 
yet, but few reports demonstrated a correlation between the 
biocontrol function of Bacillus strains and their extracellular 
protease production (Luo et al. 2013). Information about the 
Figure 1. Bis-Tris SDS PAGE (4-12%) of the antidermatophytically 
active purified ~25 kDa protein (BMAP) from the ferment broth of 
Bacillus mojavensis SZMC 22228. Lane 1, purified ~25 kDa BMAP; 
lane 2, molecular weight marker (SeeBlue Plus2 Pre-Stained Standard, 
Invitrogen-Life Technologies, Eugene, OR, USA).
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antifungal activity of extracellular proteases is available in the 
case of B. mojavensis-related B. subtilis. Its culture filtrate 
which had protease activity inhibited the growth of afla-
toxigenic Aspergilli (Thakaew and Niamsup 2013). Basurto-
Cadena et al. (2012) found connection between the presence 
of proteases and antagonistic activity of B. subtilis against 
plant pathogenic fungi such as F. verticillioides and R. solani. 
In a more detailed study, it was observed that the 41.38 kDa 
alkaline protease P6 from B. subtilis N7 effectively inhibits 
the spore germination and mycelial growth of F. oxysporum 
f.sp. cucumerium (Luo et al. 2013). Until the present study, 
antidermatophytic effect of bacterial proteases has not been 
described in the literature.
Our results indicate that the isolated ~25 kDa BMAP 
could be a promising agent in the treatment of dermatophy-
tosis, however, further in vitro and in vivo investigations and 
characterization experiments (such as MALDI-TOF analysis, 
N-terminal sequencing, enzyme kinetics, pH and thermal 
optimum/stability, ion-dependence, hematolytic and toxic 
effect, etc.) are needed.
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